Fusion Antibodies Share Discussion Threads

[bamboo2] 05/1/2018 08:35

fhasson, there's very little to go on, on the daily chart that I use, due to the newness of the ipo. The gap however is of a type that I would expect to be filled relatively soon.

[fhasson] 04/1/2018 15:29

Aim for 125 then?

[bamboo2] 04/1/2018 13:06

Chart shows a small area gap 18-19/12/2017
125-125.5 This could be a good entry point.

[fhasson] 04/1/2018 01:09

Keen to add these to my portfolio. Aiming for further retrace though! Once Car-T hits off for immuno- oncology blockbuster cures there will be more potential growth for companies like FAB. Already in the bag for monoclonal antibody treatments on a global scale which is ever- increasing but the future is MAB and Car-T for chronic disease management and cancer treatment/ cure.Should be a multi- bagger . For LTH .

[falia] 27/12/2017 15:59

cannot buy in any large numbers

[dave4545] 27/12/2017 15:53

Beware falia pump and dump

[falia] 27/12/2017 15:52

cannot buy £2.50+ tomorrow

[falia] 27/12/2017 11:24

rocket time

[gersemi] 27/12/2017 10:52

The rise continues unabated though of course the stock is quite illiquid so this can work both ways..

[fhasson] 23/12/2017 16:04

Hoping for some retrace then I am in for 3- 5 years minimum. Holding heavy with OXB which I think will complement FAB when they start to hit off. Yuletide greetings to our homegrown unicorn potential scientists at Queens

[timbo003] 20/12/2017 20:52

Interesting you should mention Horizon gersemi. Horizon were one of the peer group comparitors used in Allenby's Pre-IPO research note (see below)

[gersemi] 20/12/2017 20:29

I've been watching it and can't believe it's doubled since its flotation. Remarkable.

Another Horizon Discovery?

[timbo003] 20/12/2017 20:26

Another rather excellent day, I find it surprising that no one else appears to be interesting in FAB given that they have increased by over 120% in just three days.

[timbo003] 20/12/2017 09:23

Future revenue/earnings estimates from The Allenby pre-IPO note (dated November 2017):

[timbo003] 19/12/2017 19:48

Thanks to Anna at Walbrook for steering me in the right direction regarding videos.

Here's a link to a BRR media video of the IPO recorded at the LSE on Monday morning which includes a brief interview with Paul Kerr (CEO):

[timbo003] 19/12/2017 10:10

Another good day (so far), I have requested that ADVFN assign the correct name to the ticker (FAB) and I will find out from Walbrook whether there any any interviews or research notes now available:

[drmaccers] 18/12/2017 19:05

Numbers aren't great from the last 6 months?

[timbo003] 18/12/2017 12:56

I picked up a few EIS qualifying shares in the IPO at 82p/share, there was a bit of scale back (circa 15%).

Could these can emulate Bioventix after their AIM debut (subsequently multi-bagged)?

[timbo003] 18/12/2017 12:49

Off to a good start



* First day of dealing today (Monday 18th December)

* £5.5 million raised by the conditional placing of 6,707,317 new Ordinary Shares at a placing price of 82p

* The new Ordinary Shares represent c. 30.4 per cent. of the enlarged share capital on Admission

* Selling shareholders have sold 1,310,976 existing Ordinary Shares as part of the placing

[vivgav] 08/2/2012 21:34

It's the year of the comebacks. Graham Taylor :-)

[damanko] 08/2/2012 21:33

Have to agree with N3. Watched the game against Holland in '96 in a bamboo bar in Kampala. Awesome.... but very little since. Less than little, actually.

[supercity] 08/2/2012 21:11

maybe we can go to the euros with a bit of confidence now

[hvs] 08/2/2012 20:32

We must give him a GOOD BONUS for doing F.A. It seems to be the English
F.A. motto.

Goran Erkisson laughed all the way to the BANK.